Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Gastrointestinal Cancers
What dose and fractionation do you utilize for node positive HCC?
Related Questions
How would you manage a patient with de novo oligometastatic anal cancer with a single metastasis in the pubic bone?
Would having mucinous rectal adenocarcinoma impact your recommendation for short vs long course RT as part of a TNT regimen?
Would you dose escalate neoadjuvant radiotherapy for T3 and/or N+ rectal cancer in patients who are unwilling or unable to get chemotherapy?
How would you approach unexpected chemo breaks during planned neoadjuvant chemoradiation for esophageal adenocarcinoma?
Is there increased risk from RT in patients with FAP (familial adenomatous polyposis)?
Are the results of CONKO-007 changing practice for the management of pancreatic cancer?
How do you manage oxaliplatin-induced splenomegaly?
Given the results of PLATO anal cancer study, is 4140 cGy the new standard for early stage anal cancer?
Which GI cancer patients do you use oral contrast in staging CT scans?
What are your top takeaways from ASCO GI 2025?
